Commonwealth Coat of Arms of Australia

 

Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Amendment (No. 2) Determination 2021

I, the Hon Greg Hunt, Minister for Health and Aged Care, make the following Determination.

Dated 18 June 2021

Greg Hunt

Minister for Health and Aged Care

 

 

 

Contents

1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1— Amendments

Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Determination 2021

 

1  Name

  This instrument is the Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Amendment (No. 2) Determination 2021.

2  Commencement

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

18 June 2021

 

 Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1— Amendments

Health Insurance (Section 3C General Medical Services – General Practice Attendance for Assessing Patient Suitability for a COVID-19 Vaccine) Determination 2021

  1. Section 7

Repeal the section (not including the heading), substitute:

(1)    An item in the Schedule (other than items 10660 and 10661) applies to a service whether the service is provided:

(a)   by a medical practitioner; or

(b)   on behalf of a medical practitioner by a relevant health professional.

Note: see subsection 3(17) of the Act for when a service is taken to be rendered on behalf of a medical practitioner.

(2)   Item 10660 applies to a service provided in the course of a personal attendance by a single general practitioner on a single patient on a single occasion.

(3)   Item 10661 applies to a service provided in the course of a personal attendance by a single medical practitioner (other than a general practitioner) on a single patient on a single occasion.

 

2.     Schedule (after item 93656)

Insert:

 

Subgroup 5 – In-depth Patient Assessment for a Patient who has Received a Vaccine Suitability Assessment Service

10660

Professional attendance by a general practitioner, if all of the following apply:

(a)    the service is associated with a service to which item 93624, 93625, 93634, 93635, 93644, 93645, 93653 or 93654 applies;

(b)    the service is provided to a patient who is at least 50 years of age;

(c)    the service requires personal attendance by the general practitioner, lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine;

(d)    one or both of the following is undertaken, where clinically relevant:

(i)     a detailed patient history;

(ii)   complex examination and management;

(e)    the service is bulk-billed

45.55

10661

Professional attendance by a medical practitioner (other than a general practitioner), if all of the following apply:

(a)    the service is associated with a service to which item 93626, 93627, 93636, 93637, 93646, 93647, 93655 or 93656 applies;

(b)    the service is provided to a patient who is at least 50 years of age;

(c)    the service requires personal attendance by the medical practitioner (other than a general practitioner), lasting more than 10 minutes in duration, to provide in-depth clinical advice on the individual risks and benefits associated with receiving a COVID-19 vaccine;

(d)    one or both of the following is undertaken, where clinically relevant:

(i)       a detailed patient history;

(ii)     complex examination and management;

(e)    the service is bulk-billed

36.45